Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and efficacy of alefacept (Amevive) in adults with moderate to severe atopic dermatitis has completed, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: Rush University Medical Center | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2011-01-28